XML 74 R62.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Commitments and Contingencies - Additional Information (Detail)
$ in Millions
2 Months Ended 6 Months Ended 32 Months Ended
May 31, 2021
PutativeClassAction
Jun. 30, 2024
USD ($)
Apr. 03, 2024
ShareholderDerivative
Dec. 31, 2023
USD ($)
Oct. 17, 2023
USD ($)
Commitments And Contingencies [Line Items]          
Operating lease liability   $ 73.9      
Outstanding non-cancelable purchase obligations   19.7      
Number of complaints filed 5   7    
Litigation settlement amount       $ 28.5 $ 28.5
Manufacture and Supply of Roxadustat [Member]          
Commitments And Contingencies [Line Items]          
Outstanding non-cancelable purchase obligations   0.8      
Manufacture and Supply of Pamrevlumab [Member]          
Commitments And Contingencies [Line Items]          
Outstanding non-cancelable purchase obligations   11.2      
Other Purchases [Member]          
Commitments And Contingencies [Line Items]          
Outstanding non-cancelable purchase obligations   7.6      
Research and Preclinical Stage Development Programs [Member]          
Commitments And Contingencies [Line Items]          
Maximum future milestone payments   $ 697.9